explore -WSS

explore

author：leisure time 2025-09-30 20:20:02 - browse：714

A psilocybin mushroom lays inside a clear capsule — Adobe

A single dose of psilocybin may have enduring benefits for people with major depressive disorder, according to a randomized clinical trial published Thursday in the Journal of the American Medical Association.

Several prior studies have suggested that psilocybin, the psychedelic compound produced by certain types of mushrooms, could be a promising way to treat major depression in people for whom antidepressants or counseling aren’t effective. But those studies mostly focused on short-term results, while the new JAMA study looked at psilocybin’s efficacy up to six weeks after the administration of a single dose of psilocybin.

“It’s exciting to see another study that’s coming out that is adding to the evidence base suggesting potential efficacy of psilocybin for depression, amongst other conditions,” said Greg Fonzo, an assistant professor and co-director for the Center for Psychedelic Research and Therapy at the University of Texas at Austin’s Dell Medical School, who was not involved in the study.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： Bird flu in milk supply is likely coming from asymptomatic cows

WSS

Q&A: Jennifer Adair on making gene therapy available globally

FTC falls short on scrutinizing hospital mergers, study says

Q&A: Jennifer Adair on making gene therapy available globally

Diversity in clinical trials starts with building trust, experts say

Readout Newsletter: Amylyx, Alto Neuro, and Eli Lilly for the Oscars

Why rehabilitation engineers need to center patients in their research

Wikipedia

explore

Wikipedia

Trump demands the U.S. pay no more for drugs than other countries … again

Diversity in clinical trials starts with building trust, experts say

As demand for Covid shots wanes, Moderna seeks its next success

UnitedHealth financials solid despite Change Healthcare cyberattack

Affirmative action in medical school literally saved lives

Readout Newsletter: Acadia, Eli Lilly, Madrigal Pharma updates

Supreme Court strikes down use of affirmative action

Readout Newsletter: Amylyx, Alto Neuro, and Eli Lilly for the Oscars

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

H5N1 bird flu found in pasteurized milk: what we know

knowledge

H5N1 bird flu found in pasteurized milk: what we know

In surprise move, FDA calls for advisory committee on Lilly's Alzheimer's drug

Cholera vaccine supply gets boost as demand surges globally

First medicine developed to treat MASH expected to be approved soon

FTC falls short on scrutinizing hospital mergers, study says

Amylyx ALS drug fails large clinical trial

focus

focus

hotspot

explore